These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24075359)

  • 1. Early coverage of Bioabsorbable Scaffold after STEMI analysed by 2D and 3D optical coherence tomography.
    Foin N; Ghione M; Mattesini A; Dall'Ara G; Davies JE; Di Mario C
    Cardiovasc Revasc Med; 2013; 14(6):363-4. PubMed ID: 24075359
    [No Abstract]   [Full Text] [Related]  

  • 2. Bifurcation lesions: Bioresorbable vascular scaffold and drug coated balloon, an efficacy association. Lessons from optimal coherence tomography.
    Piraino D; Carella M; Buccheri D; Andolina G
    Int J Cardiol; 2016 Jun; 212():92-3. PubMed ID: 27038711
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular flashlight. The fate of bioresorbable struts located at a side branch ostium: serial three-dimensional optical coherence tomography assessment.
    Okamura T; Serruys PW; Regar E
    Eur Heart J; 2010 Sep; 31(17):2179. PubMed ID: 20513731
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospectively electrocardiogram-triggered high-pitch spiral acquisition coronary computed tomography angiography for assessment of biodegradable vascular scaffold expansion: comparison with optical coherence tomography.
    D'Alfonso MG; Mattesini A; Meucci F; Acquafresca M; Gensini GF; Valente S
    Cardiovasc Revasc Med; 2014; 15(8):436-8. PubMed ID: 24972513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing neointimal coverage after DES implantation by 3D OCT.
    Ha J; Kim BK; Kim JS; Shin DH; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Imaging; 2012 Aug; 5(8):852-3. PubMed ID: 22898000
    [No Abstract]   [Full Text] [Related]  

  • 6. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial.
    Guagliumi G; Costa MA; Sirbu V; Musumeci G; Bezerra HG; Suzuki N; Matiashvili A; Lortkipanidze N; Mihalcsik L; Trivisonno A; Valsecchi O; Mintz GS; Dressler O; Parise H; Maehara A; Cristea E; Lansky AJ; Mehran R; Stone GW
    Circulation; 2011 Jan; 123(3):274-81. PubMed ID: 21220730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-D optical coherence tomographic image of bifurcation lesion treated with two Absorb scaffolds.
    Sengottuvelu G; Ligthart JM; Rajendran R
    Indian Heart J; 2015; 67(1):62. PubMed ID: 25820054
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of very early stent healing after primary angioplasty: an optical coherence tomographic observational study of chromium cobaltum and first-generation drug-eluting stents. The DETECTIVE study.
    Prati F; Stazi F; Dutary J; La Manna A; Di Giorgio A; Pawlosky T; Gonzalo N; Di Salvo ME; Imola F; Tamburino C; Albertucci M; Alfonso F
    Heart; 2011 Nov; 97(22):1841-6. PubMed ID: 21880655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Online 3-dimensional rendering of optical coherence tomography images for the assessment of bifurcation intervention.
    Karanasos A; Tu S; van der Linden M; van Weenen S; Ligthart J; Regar E
    Can J Cardiol; 2012; 28(6):759.e1-3. PubMed ID: 22763361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenomenon of elongated struts: is optical coherence tomography accurate enough to analyze scaffold area?
    Kharlamov AN
    Int J Cardiol; 2013 Oct; 168(4):4280-4. PubMed ID: 23701927
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography.
    Gutiérrez-Chico JL; Regar E; Nüesch E; Okamura T; Wykrzykowska J; di Mario C; Windecker S; van Es GA; Gobbens P; Jüni P; Serruys PW
    Circulation; 2011 Aug; 124(5):612-23. PubMed ID: 21768536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue characterization after drug-eluting stent implantation using optical coherence tomography.
    Malle C; Tada T; Steigerwald K; Ughi GJ; Schuster T; Nakano M; Massberg S; Jehle J; Guagliumi G; Kastrati A; Virmani R; Byrne RA; Joner M
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1376-83. PubMed ID: 23539216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial.
    Onuma Y; Serruys PW; Perkins LE; Okamura T; Gonzalo N; García-García HM; Regar E; Kamberi M; Powers JC; Rapoza R; van Beusekom H; van der Giessen W; Virmani R
    Circulation; 2010 Nov; 122(22):2288-300. PubMed ID: 20975003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application.
    Farooq V; Onuma Y; Radu M; Okamura T; Gomez-Lara J; Brugaletta S; Gogas BD; van Geuns RJ; Regar E; Schultz C; Windecker S; Lefèvre T; Brueren BR; Powers J; Perkins LL; Rapoza RJ; Virmani R; García-García HM; Serruys PW
    EuroIntervention; 2011 Jul; 7(3):386-99. PubMed ID: 21729842
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioresorbable scaffolds for primary angioplasty: Optical coherence tomography follow-up.
    Leite L; Matos V; Silveira J; Jorge E; Silva Marques J; Pego M
    Rev Port Cardiol; 2016 Jan; 35(1):67-8. PubMed ID: 26738961
    [No Abstract]   [Full Text] [Related]  

  • 16. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geometrically correct three-dimensional optical coherence tomography: first self-expanding bifurcation stent evaluation.
    Antoniadis AP; Jaguszewski M; Maier W; Giannoglou GD; Lüscher TF; Templin C
    Eur Heart J; 2013 Sep; 34(34):2715. PubMed ID: 23832492
    [No Abstract]   [Full Text] [Related]  

  • 18. Serial optical coherence tomography imaging of the "black-hole" phenomenon by intravascular ultrasound following sirolimus-eluting stent implantation.
    Kurita T; Terashima M; Suzuki T
    EuroIntervention; 2012 Apr; 7(12):1480-1. PubMed ID: 22522560
    [No Abstract]   [Full Text] [Related]  

  • 19. Three-dimensional optical coherence tomography with the current version (E.4 [Build 10457]) of Metallic Stent Optimization Software is a mirror image.
    Nakao F
    Cardiol J; 2017; 24(3):340-341. PubMed ID: 28661000
    [No Abstract]   [Full Text] [Related]  

  • 20. Coronary stent fracture complicated multiple aneurysms confirmed by 3-dimensional reconstruction of intravascular-optical coherence tomography in a patient treated with open-cell designed drug-eluting stent.
    Kim S; Kim CS; Na JO; Choi CU; Lim HE; Kim EJ; Rha SW; Park CG; Seo HS; Oh DJ; Yoo H; Kim JW
    Circulation; 2014 Jan; 129(3):e24-7. PubMed ID: 24446412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.